p53‐Dependent Mitochondrial Compensation in Heart Failure With Preserved Ejection Fraction

p53‐Dependent Mitochondrial Compensation in Heart Failure With Preserved Ejection Fraction

Background Heart failure with preserved ejection fraction (HFpEF) accounts for 50% of patients with heart failure. Clinically, HFpEF prevalence shows age and gender biases. Although the majority of patients with HFpEF are elderly, there is an emergence of young patients with HFpEF. A better understa...

Полное описание

Библиографические подробности
Главные авторы:	Xiaonan Chen, Hao Lin, Weiyao Xiong, Jianan Pan, Shuying Huang, Shan Xu, Shufang He, Ming Lei, Alex Chia Yu Chang, Huili Zhang
Формат:	Статья
Язык:	English
Опубликовано:	Wiley 2022-06-01
Серии:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Предметы:	aging HFpEF mitochondrial homeostasis p53 activation
Online-ссылка:	https://www.ahajournals.org/doi/10.1161/JAHA.121.024582

Схожие документы

The role of coronary microvascular dysfunction in the pathogenesis of heart failure with preserved ejection fraction
по: Becker Al-Khayatt, и др.
Опубликовано: (2024-05-01)

Impact of severe obesity on exercise performance in heart failure with preserved ejection fraction
по: Satyam Sarma, и др.
Опубликовано: (2020-11-01)

iNOS contributes to heart failure with preserved ejection fraction through mitochondrial dysfunction and Akt S-nitrosylation
по: Yongzheng Guo, и др.
Опубликовано: (2023-01-01)

Distinct implications of body mass index in different subgroups of nonobese patients with heart failure with preserved ejection fraction: a latent class analysis of data from the TOPCAT trial
по: Bin Dong, и др.
Опубликовано: (2022-11-01)

Murine Models of Heart Failure With Preserved Ejection Fraction
по: Maria Valero-Muñoz, PhD, и др.
Опубликовано: (2017-12-01)

The role of cardiac magnetic resonance imaging in the assessment of heart failure with preserved ejection fraction
по: Clement Lau, и др.
Опубликовано: (2022-07-01)

Optimizing the discovery and assessment of therapeutic targets in heart failure with preserved ejection fraction
по: Gabrielle Fusco‐Allison, и др.
Опубликовано: (2021-10-01)

Worsening effect of testosterone deficiency on males with heart failure with preserved ejection fraction
по: Ahmed Hamam, и др.
Опубликовано: (2022-12-01)

Prognostic significance of the HFA‐PEFF score in patients with heart failure with preserved ejection fraction
по: Yohei Sotomi, и др.
Опубликовано: (2021-06-01)

Non-coding RNAs in the pathophysiology of heart failure with preserved ejection fraction
по: Elisabeth A. Jalink, и др.
Опубликовано: (2024-01-01)

Effects of Continuous Accelerated Pacing on Cardiac Structure and Function in Patients With Heart Failure With Preserved Ejection Fraction: Insights From the myPACE Randomized Clinical Trial
по: Kramer J. Wahlberg, и др.
Опубликовано: (2024-01-01)

Diagnostic signature for heart failure with preserved ejection fraction (HFpEF): a machine learning approach using multi-modality electronic health record data
по: Nazli Farajidavar, и др.
Опубликовано: (2022-12-01)

Proteomics and Precise Exercise Phenotypes in Heart Failure With Preserved Ejection Fraction: A Pilot Study
по: Ravi V. Shah, и др.
Опубликовано: (2023-11-01)

Myocardial RNA Sequencing Reveals New Potential Therapeutic Targets in Heart Failure with Preserved Ejection Fraction
по: José M. Inácio, и др.
Опубликовано: (2023-07-01)

Laboratory and Metabolomic Fingerprint in Heart Failure with Preserved Ejection Fraction: From Clinical Classification to Biomarker Signature
по: Alberto Palazzuoli, и др.
Опубликовано: (2023-01-01)

Stratified Treatment of Heart Failure with preserved Ejection Fraction: rationale and design of the STADIA‐HFpEF trial
по: Mariëlle Scheffer, и др.
Опубликовано: (2020-12-01)

Right Ventricular‐Vascular Uncoupling Predicts Pulmonary Hypertension in Clinically Diagnosed Heart Failure With Preserved Ejection Fraction
по: Zheng‐Wei Chen, и др.
Опубликовано: (2024-01-01)

Sodium‐glucose cotransporter 2 inhibitors in heart failure with reduced or preserved ejection fraction: a meta‐analysis
по: Arjun K. Pandey, и др.
Опубликовано: (2022-04-01)

Inflammation as a therapeutic target in heart failure with preserved ejection fraction
по: Zhen Hui Peh, и др.
Опубликовано: (2023-06-01)

Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle?
по: Mark Sweeney, и др.
Опубликовано: (2020-09-01)

The clinical relevance of quality of life in heart failure patients with preserved ejection fraction
по: Masahiro Seo, и др.
Опубликовано: (2023-04-01)

Heart Failure with Preserved Ejection Fraction (HFpEF): A Case Report
по: Amanda Halimi, и др.
Опубликовано: (2021-09-01)

Myths and Facts About Heart Failure with Preserved Ejection Fraction: Risk Factors, Longevity, Potential Pharmacological and Exercise Interventions
по: Chung-Lieh Hung, и др.
Опубликовано: (2013-03-01)

Impact of coronary microvascular dysfunction in heart failure with preserved ejection fraction: a meta‐analysis
по: Domenico D'Amario, и др.
Опубликовано: (2024-08-01)

Astragaloside IV alleviates inflammation and improves myocardial metabolism in heart failure mice with preserved ejection fraction
по: Xiao Wang, и др.
Опубликовано: (2024-11-01)

Validation of heart failure algorithm for diagnosing heart failure with preserved ejection fraction: a meta‐analysis
по: Shu Li, и др.
Опубликовано: (2023-08-01)

Prognostic value of Growth differentiation factors 15 in Acute heart failure patients with preserved ejection fraction
по: Dan Yin, и др.
Опубликовано: (2023-04-01)

Large Animal Models of Heart Failure: Reduced vs. Preserved Ejection Fraction
по: Christopher J. Charles, и др.
Опубликовано: (2020-10-01)

Diabetes and Excess Aldosterone Promote Heart Failure With Preserved Ejection Fraction
по: Bence Hegyi, и др.
Опубликовано: (2022-12-01)

Current Understanding of Molecular Pathophysiology of Heart Failure With Preserved Ejection Fraction
по: Heidi Budde, и др.
Опубликовано: (2022-07-01)

Real‐world clinical diagnostics of heart failure patients with reduced or preserved ejection fraction
по: Jenni Huusko, и др.
Опубликовано: (2020-06-01)

The Prognostic Value of Anemia in Patients with Preserved, Mildly Reduced and Recovered Ejection Fraction
по: Anita Pintér, и др.
Опубликовано: (2022-02-01)

Small Heart Size and Premature Death in 366,484 Individuals With Normal Ejection Fraction
по: Stephanie J. Rowe, BBiomed, MD, и др.
Опубликовано: (2025-01-01)

Sex differences in mortality and hospitalization in heart failure with preserved and mid-range ejection fraction: a systematic review and meta-analysis of cohort studies
по: You Deng, и др.
Опубликовано: (2024-01-01)

Identifying plasma proteomic signatures from health to heart failure, across the ejection fraction spectrum
по: Karolina Andrzejczyk, и др.
Опубликовано: (2024-06-01)

Independent predictors of developing pulmonary hypertension in heart failure with reduced versus preserved ejection fraction
по: Alaa Roushdy, и др.
Опубликовано: (2017-07-01)

Age‐stratified profiles and outcomes of patients with heart failure with preserved ejection fraction
по: Shinsuke Yamanaka, и др.
Опубликовано: (2024-08-01)

Hydrogen Sulfide as a Potential Therapy for Heart Failure—Past, Present, and Future
по: Kyle B. LaPenna, и др.
Опубликовано: (2021-03-01)

Aptamer Proteomics for Biomarker Discovery in Heart Failure With Preserved Ejection Fraction: The PARAGON‐HF Proteomic Substudy
по: Natasha L. Patel‐Murray, и др.
Опубликовано: (2024-07-01)

Incidence and risk factors of heart failure with preserved ejection fraction in elderly patients with hypertension
по: Min Chen, и др.
Опубликовано: (2024-12-01)